Business
Blue Diamond Ventures Inc. announces Strategic Partnership
Blue Diamond Ventures Inc. announces Strategic Partnership.
About this update from Blue Diamond Ventures, Inc.
[{"type":"text","content":"\n \n \n Blue Diamond Ventures Inc. announces Strategic Partnership\n \n \nBlue Diamond Ventures Inc. announces Strategic Partnership\n\nEltron R & D and BLDV join forces to make an ImPAAct(TM) (PAA) in the Cannabis Industry\n\n \n DENVER, CO--(Marketwired - May 26, 2017) -  Blue Diamond Ventures Inc. (OTC PINK: BLDV) today announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator. Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels.\n Cannabis-Clean, a wholly owned subsidiary of BLDV, will work closely with Eltron R&D to roll out the PAA. \"This is an exciting new offering; Peracetic Acid is widely used in Cannabis and other industries,\" said Josh Alper, CEO of BLDV. \"The generator is a Patented Device, the only one of its kind, that makes the PAA product on site, on demand.\"\n Steve McMorrow, President of Cannabis-Clean, said, \"We are getting up to speed quickly; this agreement gives us the exclusive for the Cannabis Industry in Colorado with a commitment to define expansion to include a partnership for the entire USA.\" On June 1st, 2017 Cannabis-Clean will be relocating its operations to the Eltron R&D facility in Boulder. \"The ImPAAct™ product has really defined our expansion strategy,\" continued McMorrow. \"We have been working with Eltron for 6 months to put this together, and it gives us a sustainable competitive advantage.\" The new Peracetic Acid Generator has already been approved by the Colorado Department of Agriculture for use in Cannabis Facilities.\n BLDV has been named the Representative of Eltron for Israel and Canada and will be facilitating the licensing of the PAA technology in those countries. Blue Diamond Ventures will also use the expertise of Eltron to help achieve the goal of bringing Targeted Cannabis Therapies from Israel to the USA and to Canada as part of the previously announced venture with AMS of Hanover, Canada.\n \"Eltron R&D provides the laboratory space, the chemists and the material scientists that complete the needs of our partners in Israel,\" says Josh Alper. \"I will be back in Israel next week to finalize our first technology sharing agreements.\" BLDV will be moving their corporate headquarters into the El...